Affinity DataIC50: 1nMAssay Description:Inhibition of human cathepsin CMore data for this Ligand-Target Pair
Affinity DataIC50: 4.60nMAssay Description:Inhibition of human cathepsin CMore data for this Ligand-Target Pair
Affinity DataIC50: 5nMAssay Description:Inhibition of cellular cathepsin C (unknown origin)More data for this Ligand-Target Pair
TargetAlcohol dehydrogenase class-3(Homo sapiens (Human))
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Affinity DataIC50: 6.10nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 6.5nMAssay Description:Inhibition of human cathepsin CMore data for this Ligand-Target Pair
Affinity DataIC50: 7.10nMAssay Description:Inhibition of mouse GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
TargetAlcohol dehydrogenase class-3(Rattus norvegicus)
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Affinity DataIC50: 9.10nMAssay Description:Inhibition of rat GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
TargetAlcohol dehydrogenase class-3(Homo sapiens (Human))
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Affinity DataIC50: 9.20nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 9.30nMAssay Description:Inhibition of human cathepsin CMore data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:Inhibition of human cathepsin CMore data for this Ligand-Target Pair
TargetAlcohol dehydrogenase class-3(Homo sapiens (Human))
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Affinity DataIC50: 11nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
TargetAlcohol dehydrogenase class-3(Homo sapiens (Human))
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Affinity DataIC50: 12nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
TargetAlcohol dehydrogenase class-3(Homo sapiens (Human))
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Affinity DataIC50: 14nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
TargetAlcohol dehydrogenase class-3(Homo sapiens (Human))
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Affinity DataIC50: 14nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 15nMAssay Description:Inhibition of human cathepsin CMore data for this Ligand-Target Pair
TargetAlcohol dehydrogenase class-3(Homo sapiens (Human))
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Affinity DataIC50: 17nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
TargetAlcohol dehydrogenase class-3(Homo sapiens (Human))
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Affinity DataIC50: 20nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
TargetAlcohol dehydrogenase class-3(Homo sapiens (Human))
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Affinity DataIC50: 20nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
TargetAlcohol dehydrogenase class-3(Homo sapiens (Human))
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Affinity DataIC50: 20nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
TargetAlcohol dehydrogenase class-3(Homo sapiens (Human))
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Affinity DataIC50: 20nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
TargetAlcohol dehydrogenase class-3(Homo sapiens (Human))
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Affinity DataIC50: 22nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
TargetAlcohol dehydrogenase class-3(Homo sapiens (Human))
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Affinity DataIC50: 22nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
TargetAlcohol dehydrogenase class-3(Homo sapiens (Human))
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Affinity DataIC50: 24nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
TargetAlcohol dehydrogenase class-3(Homo sapiens (Human))
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Affinity DataIC50: 26nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
TargetAlcohol dehydrogenase class-3(Homo sapiens (Human))
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Affinity DataIC50: 27nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 28nMAssay Description:Inhibition of human cathepsin CMore data for this Ligand-Target Pair
TargetAlcohol dehydrogenase class-3(Homo sapiens (Human))
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Affinity DataIC50: 29nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
TargetAlcohol dehydrogenase class-3(Homo sapiens (Human))
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Affinity DataIC50: 29nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
TargetAlcohol dehydrogenase class-3(Homo sapiens (Human))
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Affinity DataIC50: 30nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
TargetAlcohol dehydrogenase class-3(Homo sapiens (Human))
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Affinity DataIC50: 32nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
TargetAlcohol dehydrogenase class-3(Homo sapiens (Human))
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Affinity DataIC50: 36nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
TargetAlcohol dehydrogenase class-3(Homo sapiens (Human))
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Affinity DataIC50: 37nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
TargetAlcohol dehydrogenase class-3(Homo sapiens (Human))
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Affinity DataIC50: 38nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
TargetAlcohol dehydrogenase class-3(Homo sapiens (Human))
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Affinity DataIC50: 39nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
TargetAlcohol dehydrogenase class-3(Homo sapiens (Human))
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Affinity DataIC50: 41nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 44nMAssay Description:Inhibition of human cathepsin CMore data for this Ligand-Target Pair
TargetAlcohol dehydrogenase class-3(Homo sapiens (Human))
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Affinity DataIC50: 44nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
TargetAlcohol dehydrogenase class-3(Homo sapiens (Human))
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Affinity DataIC50: 59nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
TargetAlcohol dehydrogenase class-3(Homo sapiens (Human))
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Affinity DataIC50: 62nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
TargetAlcohol dehydrogenase class-3(Homo sapiens (Human))
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Affinity DataIC50: 62nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
TargetAlcohol dehydrogenase class-3(Homo sapiens (Human))
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Affinity DataIC50: 66nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 69nMAssay Description:Inhibition of cellular cathepsin C (unknown origin)More data for this Ligand-Target Pair
TargetAlcohol dehydrogenase class-3(Homo sapiens (Human))
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Affinity DataIC50: 74nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 78nMAssay Description:Inhibition of human cathepsin CMore data for this Ligand-Target Pair
Affinity DataIC50: 78nMAssay Description:Inhibition of human cathepsin CMore data for this Ligand-Target Pair
Affinity DataIC50: 79nMAssay Description:Inhibition of cellular cathepsin C (unknown origin)More data for this Ligand-Target Pair
TargetAlcohol dehydrogenase class-3(Homo sapiens (Human))
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Affinity DataIC50: 89nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 92nMAssay Description:Inhibition of human cathepsin CMore data for this Ligand-Target Pair
TargetAlcohol dehydrogenase class-3(Homo sapiens (Human))
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Glenmark Pharmaceuticals Limited
Curated by ChEMBL
Affinity DataIC50: 97nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 150nMAssay Description:Inhibition of cellular cathepsin C (unknown origin)More data for this Ligand-Target Pair